REQUEST A DEMO
Total
USD $0.00
Search more companies

Urogin + OOO (Урогин + ООО) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Urogin + OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Urogin + OOO (Урогин + ООО) is a company based in Russia, with its head office in Istra. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on June 13, 2017. There are currently 2 (2022) people employed by Urogin + OOO (Урогин + ООО). From the latest financial highlights, Urogin + OOO (Урогин + ООО) reported a net sales revenue drop of 8.88% in 2024. There was a total growth of 43.3% in Urogin + OOO (Урогин + ООО)’s total assets over the same period. In 2024, Urogin + OOO (Урогин + ООО)’s net profit margin increased by 14.42%.

Headquarters
Chehovskii, 5, 6
Istra; Moscow Oblast; Postal Code: 143500

Contact Details: Purchase the Urogin + OOO (Урогин + ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Urogin + OOO (Урогин + ООО) report to view the information.
Registered Capital:
Purchase the Urogin + OOO (Урогин + ООО) report to view the information.
Financial Auditors:
Purchase the Urogin + OOO (Урогин + ООО) report to view the information.
Incorporation Date:
June 13, 2017
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Urogin + OOO (Урогин + ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-8.88%
Total operating revenue
-8.88%
Operating profit (EBIT)
28.53%
Net Profit (Loss) for the Period
369.74%
Total Assets
43.3%
Total Equity
117.17%
Operating Profit Margin (ROS)
8.07%
Net Profit Margin
14.42%
Return on Equity (ROE)
29.01%
Quick Ratio
0.23%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?